dbACP: A Comprehensive Database of Anti-Cancer Peptides

118 result(s) have been found!

Accession Name Sequence Source/Organism Mechanism Assay Type Cell Line Cancer Type Activity
dbacp06803 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 46.2 ± 7.6 μM
dbacp06804 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 2.3 ± 0.2 μM
dbacp06805 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 36.2 ± 2.8 μM
dbacp06806 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 29.0 ± 3.7 μM
dbacp06807 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 6.4 ± 0.6 μM
dbacp06808 [C/U, G1K, L5Y, K8R]cGm KURRYUYRQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HL-60 Leukemia Cancer CC50 = 33.3 ±7.4μM
dbacp06809 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 26.5 ± 2.4 μM
dbacp06810 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 2.0 ± 0.1 μM
dbacp06811 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 20.9 ± 1.4 μM
dbacp06812 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 15.2 ± 1.9 μM
dbacp06813 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 1.3 ± 0.1 μM
dbacp06814 [G1K, L5Y, K8R]cGm KCRRYCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HL-60 Leukemia Cancer CC50 = 15.7 ±1.1μM
dbacp06815 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 22.5 ± 3.3 μM
dbacp06816 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 3.0 ± 0.1 μM
dbacp06817 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 51.5 ± 3.9 μM
dbacp06818 [D-P L-P]cGm GCRRLCYKQRCVTYCRGpPR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 3.9 ± 0.2 μM
dbacp06819 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 51.0 ± 4.6 μM
dbacp06820 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 4.6 ± 0.2 μM
dbacp06821 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 > 64 μM
dbacp06822 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 37.5 ± 3.3 μM
dbacp06823 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 1.4 ± 0.2 μM
dbacp06824 [C/U]cGm GURRLUYKQRUVTYURGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HL-60 Leukemia Cancer CC50 = 38.5 ± 4.8 μM
dbacp06825 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 19.5 ± 0.5 μM
dbacp06826 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 1.7 ± 0.1 μM
dbacp06827 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 44.2 ± 2.2μM
dbacp06828 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 6.7 ± 0.7 μM
dbacp06829 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 2.1 ± 0.2 μM
dbacp06830 [G1K, K8R]cGm KCRRLCYRQRCVTYCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HL-60 Leukemia Cancer CC50 = 9.0 ± 1.1μM
dbacp06831 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 > 64 μM
dbacp06832 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 10.3 ± 1.1 μM
dbacp06833 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 > 64 μM
dbacp06834 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 48.4 ± 0.7 μM
dbacp06835 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 11.5 ± 0.6 μM
dbacp06836 [R4A, R18A]cGm GCRALCYKQRCVTYCRGA Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HL-60 Leukemia Cancer CC50 = 34.1 ± 3.9 μM
dbacp06837 [Y7W, K8R, Y14W]cGm GCRRLCWRQRCVTWCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay CRL-1739 Gastric Cancer CC50 = 31.6 ± 1.3 μM
dbacp06838 [Y7W, K8R, Y14W]cGm GCRRLCWRQRCVTWCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MM96L Skin Cancer CC50 = 5.4 ± 0.3 μM
dbacp06839 [Y7W, K8R, Y14W]cGm GCRRLCWRQRCVTWCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay HeLa Cervical Cancer CC50 = 41.0 ± 4.2 μM
dbacp06840 [Y7W, K8R, Y14W]cGm GCRRLCWRQRCVTWCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay MCF-7 Breast Cancer CC50 = 15.1 ± 1.4 μM
dbacp06841 [Y7W, K8R, Y14W]cGm GCRRLCWRQRCVTWCRGR Synthetic Analogue of Gomesin Cell membrane penetration Resazurin dye assay K-562 Leukemia Cancer CC50 = 3.9 ± 0.1 μM
dbacp07023 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 15.05 ± 8.51 µM
dbacp07024 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 31.63 ± 1.56 µM
dbacp07025 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 14.52 ± 1.44 µM
dbacp07026 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 14.75 ± 7.35 µM
dbacp07027 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 22.36 ± 6.07 µM
dbacp07028 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 13.04 ± 1.99 µM
dbacp07029 [G10a]-SHa FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 15.25 ± 0.80 µM
dbacp07030 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 5.69 ± 1.46 µM
dbacp07031 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 14.31 ± 1.37 µM
dbacp07032 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 3.79 ± 1.61 µM
dbacp07033 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 4.42 ± 0.06 µM
dbacp07034 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 8.71 ± 0.35 µM
dbacp07035 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 6.31 ± 0.66 µM
dbacp07036 [G10a]2-SHa FLSGIVGMLaKLFKFLKaLMFLSGIVG Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 4.72 ± 0.36 µM
dbacp07037 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 3.77 ± 0.12 µM
dbacp07038 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay HepG-2 Liver Cancer IC50 = 5.49 ± 0.37 µM
dbacp07039 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 3.74 ± 3.46 µM
dbacp07040 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 2.31 ± 0.08 µM
dbacp07041 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 6.94 ± 0.27 µM
dbacp07042 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 1.84 ± 0.17 µM
dbacp07043 [G10a]3-SHa FLSGIVGMLaKLFFLSGIVGMLaKLFFLSGIVGMLaKLFKK Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 2.24 ± 0.05 µM
dbacp07044 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MCF-7 Breast Cancer IC50 = 35.71 ± 8.50 µM
dbacp07045 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-549 Lung Cancer IC50 = 70.71 ± 5.39 µM
dbacp07046 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay A-2780 Ovarian Cancer IC50 = 33.92 ± 5.90 µM
dbacp07047 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MiaPaCa.2 Pancreatic Cancer IC50 = 57.45 ± 6.03 µM
dbacp07048 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay PC-3 Prostate Cancer IC50 = 57.99 ± 5.04 µM
dbacp07049 Jeff-[G10a]2-SHa FLSGIVGMLaKLF-jeff-FLSGIVGMLaKLF Analog of temporin SHa Dendrimerization enhances stability, selectivity, anticancer efficacy Resazurin dye assay MNT-1 Skin Cancer IC50 = 57.03 ± 6.09 µM
dbacp07468 Protonectin ILGTILGLLKGL Parachartergus fraternus Cell penetration without toxic accumulation Resazurin dye assay MM96L Skin Cancer CC50 = 14.8 ± 0.9 µM
dbacp07469 Protonectin ILGTILGLLKGL Parachartergus fraternus Cell penetration without toxic accumulation Resazurin dye assay HCT-116 Colon Cancer CC50 = 8.0 ± 0.5 µM
dbacp07470 Protonectin-F IFGTILGFLKGL Protonoectin Cell penetration without toxic accumulation Resazurin dye assay MM96L Skin Cancer CC50 = 16.0 ± 1.2 µM
dbacp07471 Protonectin-F IFGTILGFLKGL Protonoectin Cell penetration without toxic accumulation Resazurin dye assay HCT-116 Colon Cancer CC50 = 9.8 ± 1.2 µM
dbacp07803 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 1.3 ± 0.1 µM
dbacp07804 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 1.4 ± 0.1 µM
dbacp07805 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 2.7 ± 0.1 µM
dbacp07806 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 2.7 ± 0.3 µM
dbacp07807 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 2.0 ± 0.1 µM
dbacp07808 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay MCF-7 Breast Cancer CC50 = 6.4 ± 0.6 µM
dbacp07809 cT1 KWCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 6.7 ± 0.6 µM
dbacp07810 [R/K]cT1 KWCFKVCYKGICYKKCKG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 4.3 ± 0.3 µM
dbacp07811 [R/K]cT1 KWCFKVCYKGICYKKCKG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 3.5 ± 0.4 µM
dbacp07812 [R/K]cT1 KWCFKVCYKGICYKKCKG Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 2.5 ± 0.1 µM
dbacp07813 [R/K]cT1 KWCFKVCYKGICYKKCKG Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 13.4 ± 1.9 µM
dbacp07814 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 2.0 ± 0.1 µM
dbacp07815 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 3.0 ± 0.2 µM
dbacp07816 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 3.9 ± 0.2 µM
dbacp07817 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 18.9 ± 0.9 µM
dbacp07818 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 2.7 ± 0.2 µM
dbacp07819 [W2S]cT1 KSCFRVCYRGICYRRCRG Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 22.5 ± 2.1 µM
dbacp07820 [Y8S-I11S]cT1 KWCFRVCSRGSCYRRCRG Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 17.3 ± 1.0 µM
dbacp07821 [Y8S-I11S]cT1 KWCFRVCSRGSCYRRCRG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 27.8 ± 2.2 µM
dbacp07822 [Y8S-I11S]cT1 KWCFRVCSRGSCYRRCRG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 28.2 ± 2.0 µM
dbacp07823 [Y8S-I11S]cT1 KWCFRVCSRGSCYRRCRG Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 13.2 ± 0.9 µM
dbacp07824 [R9S]cT1 KWCFRVCYSGICYRRCRG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 5.3 ± 0.6 µM
dbacp07825 [R14S]cT1 KWCFRVCYRGICYSRCRG Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 1.7 ± 0.1 µM
dbacp07826 [R14S]cT1 KWCFRVCYRGICYSRCRG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 2.3 ± 0.2 µM
dbacp07827 [R14S]cT1 KWCFRVCYRGICYSRCRG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 2.7 ± 0.1 µM
dbacp07828 [R14S]cT1 KWCFRVCYRGICYSRCRG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 3.5 ± 0.3 µM
dbacp07829 [R14S]cT1 KWCFRVCYRGICYSRCRG Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 7.5 ± 0.3 µM
dbacp07830 [R17S]cT1 KWCFRVCYRGICYRRCSG Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 1.8 ± 0.1 µM
dbacp07831 [R17S]cT1 KWCFRVCYRGICYRRCSG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 1.2 ± 0.1 µM
dbacp07832 [R17S]cT1 KWCFRVCYRGICYRRCSG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 1.8 ± 0.1 µM
dbacp07833 [R17S]cT1 KWCFRVCYRGICYRRCSG Synthetic Not Available Resazurin dye assay MDA-MB-435S Skin Cancer CC50 = 4.5 ± 0.3 µM
dbacp07834 [R17S]cT1 KWCFRVCYRGICYRRCSG Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 12.2 ± 0.4 µM
dbacp07835 [R9S-R14S-R17S]cT1 KWCFRVCYSGICYSRCSG Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 11.8 ± 0.9 µM
dbacp07836 [R9S-R14S-R17S]cT1 KWCFRVCYSGICYSRCSG Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 11.1 ± 0.9 µM
dbacp07837 [R9S-R14S-R17S]cT1 KWCFRVCYSGICYSRCSG Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 4.8 ± 0.3 µM
dbacp07838 [G18K]cT1 KWCFRVCYRGICYRRCRK Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 1.0 ± 0.1 µM
dbacp07839 [G18K]cT1 KWCFRVCYRGICYRRCRK Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 3.2 ± 0.1 µM
dbacp07840 [G18K]cT1 KWCFRVCYRGICYRRCRK Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 2.7 ± 0.2 µM
dbacp07841 [G18K]cT1 KWCFRVCYRGICYRRCRK Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 1.7 ± 0.1 µM
dbacp07842 [G18K]cT1 KWCFRVCYRGICYRRCRK Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 6.7 ± 1.1 µM
dbacp07843 [I11F-G18K]cT1 KWCFRVCYRGFCYRRCRK Synthetic Not Available Resazurin dye assay MM96L Skin Cancer CC50 = 1.3 ± 0.1 µM
dbacp07844 [I11F-G18K]cT1 KWCFRVCYRGFCYRRCRK Synthetic Not Available Resazurin dye assay HT-144 Skin Cancer CC50 = 3.2 ± 0.1 µM
dbacp07845 [I11F-G18K]cT1 KWCFRVCYRGFCYRRCRK Synthetic Not Available Resazurin dye assay WM164 Skin Cancer CC50 = 2.9 ± 0.2 µM
dbacp07846 [I11F-G18K]cT1 KWCFRVCYRGFCYRRCRK Synthetic Not Available Resazurin dye assay K-562 Leukemia Cancer CC50 = 1.9 ± 0.1 µM
dbacp07847 [I11F-G18K]cT1 KWCFRVCYRGFCYRRCRK Synthetic Not Available Resazurin dye assay HeLa Cervical Cancer CC50 = 5.1 ± 0.3 µM
dbacp07934 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-87-MG Brain Tumor IC50 = 29.20 ± 7.96 µM
dbacp07935 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay U-373-MG Brain Tumor IC50 = 20.94 ± 5.18 µM
dbacp07936 LyeTx-I-b IWLTALKFLGKNLGKLAKQQLAKL Synthetic Membrane disruption, necroptosis, limited apoptosis MTT/Resazurin dye assay SH-SY5Y Brain Tumor IC50 = 93.80 ± 2.17 µM